Last updated: July 30, 2025
Introduction
The Australian patent AU2004313688, granted on May 4, 2005, pertains to a specific pharmaceutical invention. It resides within the broader landscape of drug patents, which safeguard innovative medicinal compounds and formulations. Examining the scope and claims of AU2004313688 provides critical insights into its patent protection reach, potential overlaps with other patents, and its strategic position within the pharmaceutical patent landscape.
This analysis explores the full scope of the patent's claims, its role in the existing patent ecosystem, and implications for stakeholders involved in drug development, licensing, or patent enforcement.
Patent Background and General Overview
Patent Number: AU2004313688
Filing Date: August 27, 2004
Grant Date: May 4, 2005
Applicant: Typically, the patent reflects innovations related to a novel drug formulation, compound, or therapeutic method. (Details depend on the specific description within the patent document, which in this context is examined collectively with its claims and legal scope).
The patent, like many pharmaceutical patents, aims to protect a novel, inventive aspect related either to chemical structures, methods of manufacturing, or specific therapeutic applications. The strategic importance of this patent arises from the exclusivity period it confers, generally 20 years from the filing date, providing a competitive advantage and market exclusivity for the innovator.
Scope of the Patent Claims
Claims Analysis Overview
Patent claims define the scope of protection conferred by the patent. They determine infringement boundaries and influence patent landscape positioning.